1. Recovery of myofilament function through reactivation of glycogen synthase kinase 3β (GSK-3β): mechanism for cardiac resynchronization therapy

   • Syed Raza Shah
   • Kaneez Fatima
   • Mehreen Ansari

   Commentary 26 September 2014 Pages: 193 - 194

2. Ventricular tachyarrhythmia recurrence in primary versus secondary implantable cardioverter-defibrillator patients and role of electrophysiology study

   • Sarah Zaman
   • Gopal Sivagangabalan
   • Pramesh Kovoor

   OriginalPaper 30 September 2014 Pages: 195 - 202

   

3. Implantable cardioverter defibrillator remote monitoring is well accepted and easy to use during long-term follow-up

   • Loredana Morichelli
   • Antonio Porfili
   • Renato Pietro Ricci

   OriginalPaper 26 September 2014 Pages: 203 - 209

   

4. Influence of QRS duration on outcome of death or appropriate defibrillator therapy by strategy of left ventricular lead placement in cardiac resynchronization therapy recipients

   • Samir Saba
   • Josef Marek
   • John Gorcsan

   OriginalPaper 13 November 2014 Pages: 211 - 215

   

5. Longitudinal follow-up of Riata leads reveals high annual incidence of new conductor externalization and electrical failure

   • Christian Steinberg
   • Jean-François Sarrazin
   • Gilles O’Hara

   MULTIMEDIA REPORT 16 November 2014 Pages: 217 - 222

   

6. Paced QRS axis as a predictor of pacing-induced left ventricular dysfunction

   • Sung-Hwan Kim
   • Yong-Seog Oh
   • Tai-Ho Rho

   OriginalPaper 08 November 2014 Pages: 223 - 229

   

7. A comparison of bleeding complications between warfarin, dabigatran, and rivaroxaban in patients undergoing cryoballoon ablation

   • David Snipelisky
   • Jordan C. Ray
   • Fred Kusumoto

   OriginalPaper 08 November 2014 Pages: 231 - 236

   

8. The benefit of tissue contact monitoring with an electrical coupling index during ablation of typical atrial flutter—a prospective randomised control trial

   • Michael A. Jones
   • David Webster
   • Timothy R. Betts

   OriginalPaper 19 September 2014 Pages: 237 - 244

   

9. Electrophysiological study 6 months after Epicor^™ high-intensity focused ultrasound atrial fibrillation ablation

   • Rodrigue Garcia
   • Frédéric Sacher
   • Pierre Jaïs

   OriginalPaper 09 November 2014 Pages: 245 - 251

   

10. Impact of baseline atrial fibrillation cycle length on acute and long-term outcome of persistent atrial fibrillation ablation

    • S. Ammar
    • G. Hessling
    • I. Deisenhofer

    OriginalPaper 10 July 2014 Pages: 253 - 259

    

11. Fluoroscopy-free recrossing of the interatrial septum during left atrial ablation procedures

    • Nikola Pavlović
    • Tobias Reichlin
    • Christian Sticherling

    OriginalPaper 15 November 2014 Pages: 261 - 266

    

12. Catheter ablation versus anti-arrhythmic drug therapy for the management of a trial fibrillation: a meta-analysis

    • Xiaofeng Cheng
    • Xiaoqing Li
    • Jianbo Hu

    REVIEWS 04 December 2014 Pages: 267 - 272

    

13. Transseptal access in pediatric and congenital electrophysiology procedures: defining risk

    • Johannes C. von Alvensleben
    • Macdonald Dick II
    • Martin J. LaPage

    OriginalPaper 22 November 2014 Pages: 273 - 277